Prove the boundary. Preserve the clinical workflow.
Clinical network segmentation testing should answer which sources can reach which services, and whether that matches the hospital’s approved care model. We scope prohibited paths alongside the dependencies that must remain available. Clinical engineering and relevant suppliers help define safe methods; a VLAN diagram or a failed connection alone is not proof of effective isolation.
- Define source, destination, service, expected decision and safety limits for each case.
- Separate configuration evidence, observed reachability and demonstrated application access.
- Retest the unwanted path and the legitimate workflow after an approved correction.
Outline your hospital testing scope · Use the validation matrix
The boundary worth testing
A network diagram records intent. Hospital estates need evidence of the actual source-to-destination paths, including legacy exceptions and shared services required for clinical operations.
An administrative support session may cross from a vendor access broker into recovery management. A working backup may still depend on an unavailable identity provider before a restored clinical application can be used. We connect these technical details to an agreed service boundary.
What the scope can include
- Administrative-to-clinical and supplier-to-management paths
- EHR, PACS and integration-engine dependencies
- Identity, DNS and monitoring routes across security zones
- Explicit exclusions for sensitive connected equipment
The final proposal identifies the specific applications, accounts, environments and interfaces included. It also states which prerequisites your team or a supplier must provide.
What useful proof looks like
Test a controlled matrix of approved hosts, ports and application permissions. Correlate each result with the firewall rule and service owner. Use vendor-approved test endpoints rather than scanning every connected device.
Preserve UTC time, asset identifier, requesting principal, expected decision and observed response. State-changing tests need confirmation from the resulting object or a trusted audit record. Denied operations and effective controls remain part of the outcome.
Safety and assessment limits
A successful connection is not proof of device compromise. Hardware, firmware, medical-device function and treatment workflows remain separate scope items.
Agree stop conditions with clinical operations and biomedical engineering. Exclude treatment changes and active interrogation of sensitive devices unless specifically approved. Use a canary clinical workflow, controlled rates and a named on-call decision maker for every test window.
Close the loop
Connect each weakness to a named owner, immediate safeguard and durable correction. Define positive and negative retest cases so the change restores the intended boundary while preserving legitimate use. Open items retain their dependencies and deadlines.
Preview the sector sample report to see the evidence and treatment-plan format.
